163 related articles for article (PubMed ID: 10348746)
21. Structure-activity relationships for six ketolide antibiotics.
Champney WS; Tober CL
Curr Microbiol; 2001 Mar; 42(3):203-10. PubMed ID: 11270656
[TBL] [Abstract][Full Text] [Related]
22. Erythromycin, roxithromycin, and clarithromycin: use of slow-binding kinetics to compare their in vitro interaction with a bacterial ribosomal complex active in peptide bond formation.
Dinos GP; Connell SR; Nierhaus KH; Kalpaxis DL
Mol Pharmacol; 2003 Mar; 63(3):617-23. PubMed ID: 12606769
[TBL] [Abstract][Full Text] [Related]
23. Tight binding of clarithromycin, its 14-(R)-hydroxy metabolite, and erythromycin to Helicobacter pylori ribosomes.
Goldman RC; Zakula D; Flamm R; Beyer J; Capobianco J
Antimicrob Agents Chemother; 1994 Jul; 38(7):1496-500. PubMed ID: 7979278
[TBL] [Abstract][Full Text] [Related]
24. Effect of sub-inhibitory concentrations of clarithromycin and erythromycin on the production of Staphylococcus aureus capsules.
Ohtomo T; Ohshima Y; Usui Y; Ichiman Y; Yanagisawa N; Yokota E; Shimada J
J Chemother; 1995 Nov; 7 Suppl 4():9-11. PubMed ID: 8904089
[No Abstract] [Full Text] [Related]
25. Preferential inhibition of protein synthesis by ketolide antibiotics in Haemophilus influenzae cells.
Champney WS; Tober CL
Curr Microbiol; 2003 Feb; 46(2):103-8. PubMed ID: 12520364
[TBL] [Abstract][Full Text] [Related]
26. Erythromycin-inducible resistance in Staphylococcus aureus: requirements for induction.
Weisblum B; Siddhikol C; Lai CJ; Demohn V
J Bacteriol; 1971 Jun; 106(3):835-47. PubMed ID: 4397638
[TBL] [Abstract][Full Text] [Related]
27. Potential of macrolide antibiotics to inhibit protein synthesis of Pseudomonas aeruginosa: suppression of virulence factors and stress response.
Tateda K; Ishii Y; Matsumoto T; Kobayashi T; Miyazaki S; Yamaguchi K
J Infect Chemother; 2000 Mar; 6(1):1-7. PubMed ID: 11810524
[TBL] [Abstract][Full Text] [Related]
28. Erythromycin inhibition of 50S ribosomal subunit formation in Escherichia coli cells.
Usary J; Champney WS
Mol Microbiol; 2001 May; 40(4):951-62. PubMed ID: 11401702
[TBL] [Abstract][Full Text] [Related]
29. Evernimicin (SCH27899) inhibits both translation and 50S ribosomal subunit formation in Staphylococcus aureus cells.
Champney WS; Tober CL
Antimicrob Agents Chemother; 2000 Jun; 44(6):1413-7. PubMed ID: 10817686
[TBL] [Abstract][Full Text] [Related]
30. Bacterial ribosomal subunit synthesis: a novel antibiotic target.
Champney WS
Curr Drug Targets Infect Disord; 2001 May; 1(1):19-36. PubMed ID: 12455231
[TBL] [Abstract][Full Text] [Related]
31. Activities of two novel macrolides, GW 773546 and GW 708408, compared with those of telithromycin, erythromycin, azithromycin, and clarithromycin against Haemophilus influenzae.
Kosowska K; Credito K; Pankuch GA; Hoellman D; Lin G; Clark C; Dewasse B; McGhee P; Jacobs MR; Appelbaum PC
Antimicrob Agents Chemother; 2004 Nov; 48(11):4113-9. PubMed ID: 15504829
[TBL] [Abstract][Full Text] [Related]
32. Comparative Study of the Effect of Macrolide Antibiotics Erythromycin, Clarithromycin, and Azithromycin on the ERG1 Gene Expression in H9c2 Cardiomyoblast Cells.
Hajimirzaei N; Khalili NP; Boroumand B; Safari F; Pourhosseini A; Judi-Chelan R; Tavakoli F
Drug Res (Stuttg); 2020 Aug; 70(8):341-347. PubMed ID: 32559772
[TBL] [Abstract][Full Text] [Related]
33. Postantibiotic effect and postantibiotic sub-mic effect of dirithromycin and erythromycin against respiratory tract pathogenic bacteria.
Dornbusch K; Olofsson C; Holm S
APMIS; 1999 May; 107(5):505-13. PubMed ID: 10335955
[TBL] [Abstract][Full Text] [Related]
34. Telithromycin inhibition of protein synthesis and 50S ribosomal subunit formation in Streptococcus pneumoniae cells.
Champney WS; Pelt J
Curr Microbiol; 2002 Nov; 45(5):328-33. PubMed ID: 12232662
[TBL] [Abstract][Full Text] [Related]
35. Antipneumococcal activities of two novel macrolides, GW 773546 and GW 708408, compared with those of erythromycin, azithromycin, clarithromycin, clindamycin, and telithromycin.
Matic V; Kosowska K; Bozdogan B; Kelly LM; Smith K; Ednie LM; Lin G; Credito KL; Clark CL; McGhee P; Pankuch GA; Jacobs MR; Appelbaum PC
Antimicrob Agents Chemother; 2004 Nov; 48(11):4103-12. PubMed ID: 15504828
[TBL] [Abstract][Full Text] [Related]
36. Linezolid is a specific inhibitor of 50S ribosomal subunit formation in Staphylococcus aureus cells.
Champney WS; Miller M
Curr Microbiol; 2002 May; 44(5):350-6. PubMed ID: 11927986
[TBL] [Abstract][Full Text] [Related]
37. Direct evidence for antipseudomonal activity of macrolides: exposure-dependent bactericidal activity and inhibition of protein synthesis by erythromycin, clarithromycin, and azithromycin.
Tateda K; Ishii Y; Matsumoto T; Furuya N; Nagashima M; Matsunaga T; Ohno A; Miyazaki S; Yamaguchi K
Antimicrob Agents Chemother; 1996 Oct; 40(10):2271-5. PubMed ID: 8891128
[TBL] [Abstract][Full Text] [Related]
38. Erythromycin inhibits the assembly of the large ribosomal subunit in growing Escherichia coli cells.
Chittum HS; Champney WS
Curr Microbiol; 1995 May; 30(5):273-9. PubMed ID: 7766155
[TBL] [Abstract][Full Text] [Related]
39. TAN-1057A: a translational inhibitor with a specific inhibitory effect on 50S ribosomal subunit formation.
Champney WS; Pelt J; Tober CL
Curr Microbiol; 2001 Nov; 43(5):340-5. PubMed ID: 11688798
[TBL] [Abstract][Full Text] [Related]
40. Erythromycin- and chloramphenicol-induced ribosomal assembly defects are secondary effects of protein synthesis inhibition.
Siibak T; Peil L; Xiong L; Mankin A; Remme J; Tenson T
Antimicrob Agents Chemother; 2009 Feb; 53(2):563-71. PubMed ID: 19029332
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
